Log In
BCIQ
Print this Print this
 

budiodarone (ATI-2042)

  Manage Alerts
Collapse Summary General Information
Company Armetheon Inc.
DescriptionAntiarrhythmic amiodarone analog
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationTachycardia
Indication DetailsTreat ventricular tachycardia (VT) in patients with an implantable cardioverter defibrillator
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/26/2016

0

0

0

Get a free BioCentury trial today